Jaguar Health, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by Jaguar Animal Health, Inc. on June 20, 2016, covering events that occurred on June 14, 2016, during the Company's Annual Meeting of Stockholders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance and stockholder voting results rather than financial performance.
Material Changes and Voting Results
Stockholders approved three key proposals at the Annual Meeting:
- Election of Directors: James J. Bochnowski and Lisa A. Conte were elected as Class I directors for a three-year term. Both received majority support, with approximately 5.2 million votes cast "For" each candidate.
- Ratification of Auditors: Stockholders ratified the selection of BDO USA, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2016, with over 7 million votes cast "For".
- Stock Incentive Plan: Stockholders approved the Amended and Restated 2014 Stock Incentive Plan. Approximately 5.2 million votes were cast "For" the proposal.
Guidance, Outlook, and Risks
The filing does not contain management commentary on future guidance, outlook, or specific risks. It references the Definitive Proxy Statement filed on April 29, 2016, for detailed descriptions of the Amended Plan and other matters.
Investor Verification Checklist
- Review the Definitive Proxy Statement (Schedule 14A) filed on April 29, 2016, for full details on the Amended 2014 Stock Incentive Plan.
- Verify the terms of the Amended Plan attached as Exhibit 10.1 to this filing.
- Confirm the tenure of the newly elected directors (James J. Bochnowski and Lisa A. Conte) through the 2019 annual meeting.